Eastern Cooperative Oncology Group: Breast Neoplasms trials

The registry lists 20 Breast Neoplasms studies with Eastern Cooperative Oncology Group as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 2 3Phase 3 6No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion ProtocolNot yet recruitingNCT06786585
• COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) ParticipationTerminatedNCT05076266Results posted
• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01242800Not applicableResults posted
• Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100CompletedNCT00899418
• Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With ChemotherapyCompletedNCT00897299
• Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or AcquaintanceCompletedNCT00309933
• Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerCompletedNCT00303914
• Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast CancerCompletedNCT00090974
• Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT00028990Phase 3
• Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast CancerCompletedNCT00026286Phase 3
• Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph NodesCompletedNCT00004125Phase 3
• Combination Chemotherapy in Treating Women With Breast CancerCompletedNCT00003519Phase 3
• Identification of Genes Associated With Cancer in Patients and Siblings Who Have CancerCompletedNCT00003329
• Chemotherapy in Treating Women With Previously Treated Metastatic Breast CancerCompletedNCT00003236Phase 2
• Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following ChemotherapyCompletedNCT00003010Phase 3
• Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In SituTerminatedNCT00002934Phase 2
• Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast CancerCompletedNCT00002826Phase 2
• Pain Control in Patients With Recurrent or Metastatic Breast or Prostate CancerTerminatedNCT00002668Not applicable
• Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast CancerCompletedNCT00002646Phase 3
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerCompletedNCT00002520Not applicable